The potential risks of C-C chemokine receptor 5-edited babies in bone development

被引：0

作者：

Yong Xie ^{[1
]}

Shaohua Zhan ^{[2
]}

Wei Ge ^{[2
]}

Peifu Tang ^{[1
]}

机构：

[1] Department of Orthopedics,Chinese PLA General Hospital

[2] State Key Laboratory of Medical Molecular Biology and Department of Immunology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences

来源：

Bone Research | 2019年 / 01期

基金：

中国国家自然科学基金;

关键词：

CCR; The potential risks of C-C chemokine receptor 5-edited babies in bone development;

D O I：

暂无

中图分类号：

R714.8 [];

学科分类号：

摘要：

INTRODUCTION Hutter et al.1first reported that a bone marrow transplant using stem cells derived from a donor with homozygous CCR5 delta32gene mutation remained HIV-positive but virus-free (below the limits of detection) after halting antiretroviral therapy.Since this observation in 2009,mutation of the CCR5 gene has become an important target in the prevention and treatment of HIV infection.

引用

页码：118 / 121

页数：4

共 50 条

[41] Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury
Gomez Victoria, Edna Constanza
de Brito Toscano, Eliana Cristina
de Sousa Cardoso, Ana Clara
da Silva, Daniele Goncalves
de Miranda, Aline Silva
Barcelos, Luciola da Silva
Sugimoto, Michelle Adriane
Sousa, Lirlandia Pires
de Assis Lima, Isabel Vieira
Pinheiro de Oliveira, Antonio Carlos
Brant, Fatima
Machado, Fabiana Simao
Teixeira, Mauro Martins
Teixeira, Antonio Lucio
Rachid, Milene Alvarenga
CURRENT NEUROVASCULAR RESEARCH, 2017, 14 (02) : 125 - 131
[42] C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
Wang, Xiangzi
Niu, Xiaofei
Wang, Yingkai
Liu, Yang
Yang, Cheng
Chen, Xuyi
Qi, Zhongquan
NEURAL REGENERATION RESEARCH, 2025, 20 (08) : 2231 - 2244
[43] Epigenetic up-regulation of c-c chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells
Mori, T
Kim, J
Yamano, T
Takeuchi, H
Huang, S
Umetani, N
Koyanagi, K
Hoon, DSB
CANCER RESEARCH, 2005, 65 (05) : 1800 - 1807
[44] Toxicogenomics of the C-C chemokine receptor type 5 (CCR5): Exploring the potential impacts of chemical-CCR5 interactions on inflammation and human health
Ellwanger, Joel Henrique
Chies, Jose Artur Bogo
FOOD AND CHEMICAL TOXICOLOGY, 2024, 186
[45] Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
Kalinowska, Alicja
Losy, Jacek
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (09) : 1267 - 1279
[46] Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
Bird, JE
Giancarli, MR
Kurihara, T
Kowala, MC
Valentine, MT
Gitlitz, PH
Pandya, DG
French, MH
Durham, SK
KIDNEY INTERNATIONAL, 2000, 57 (01) : 129 - 136
[47] Eotaxins and C-C chemokine receptor type 3 in Parkinson's disease
Moghadam-Ahmadi, Amir
Khorramdelazad, Hossein
Hassanshahi, Gholamhossein
Shahsavari, Sasan
Moadab, Ali
Vakilian, Alireza
ACTA NEUROLOGICA BELGICA, 2020, 120 (03) : 589 - 594
[48] C-C chemokine receptor regulates the antibody response to DNP-KLH
Vines, Charlotte
Welch, T.
Fang, Li
Kaiser, Brian
Islam, Shamima
Bill, Charles
Sun, Yuning
McBurney, Tiffany
JOURNAL OF IMMUNOLOGY, 2013, 190
[49] C-C chemokine receptor type 1 is a prognostic indicator in ovarian cancer
Chanana, Anita M.
Krishnan, Venkatesh
Tallapragada, Supreeti
Dorigo, Oliver
CANCER RESEARCH, 2019, 79 (13)
[50] Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2
Do, Catherine
Drel, Viktor
Tan, Chunyan
Lee, Doug
Wagner, Brent
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (10) : 2134 - +

← 1 2 3 4 5 →